Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daksha Mehta
Observed name:
Daksha P. Mehta
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital
Observed institutions:
University of North Carolina at Chapel Hill,
Wayne State University,
Homi Bhabha National Institute,
Tata Memorial Hospital,
University of Illinois Chicago,
Jesse Brown VA Medical Center
show all 6
OpenAlex ID:
A5111942007
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
2018
·
Désirée van der Heijde
, James Cheng-Chung Wei
, et al.
·
The Lancet
·
408
PDF
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
2013
·
Frank Buttgereit
, Daksha Mehta
, et al.
·
Annals of the Rheumatic Diseases
·
210
PDF
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
2023
·
Vikas Ostwal
, Sarika Mandavkar
, et al.
·
Journal of Clinical Oncology
·
44
Heparin‐induced thrombocytopenia and thrombosis: Reversal with streptokinase a case report and review of literature
1991
·
Daksha P. Mehta
, Ernest L. Yoder
, et al.
·
American Journal of Hematology
·
35
Mucoepidermoid Carcinoma of the Lung with Intracranial Metastases
1988
·
Karen M. Wolf
, Daksha Mehta
, et al.
·
CHEST Journal
·
13
Trastuzumab (T) plus gemcitabine-cisplatin (GC) for treatment naïve HER2 positive biliary tract adenocarcinomas (BTC): A multicentre open-label, phase II study (TAB).
2023
·
Vikas S. Ostwal
, Sarika Mandavkar
, et al.
·
Journal of Clinical Oncology
·
2
Fri0150 Gs-9876, a Novel, Highly Selective, Syk Inhibitor in Patients With Active Rheumatoid Arthritis: Safety, Tolerability and Efficacy Results of a Phase 2 Study
2019
·
Alan Kivitz
, Daksha Mehta
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
Show more works
View as search
Works count:
7
Citation count:
714
H-index:
5
I10-index:
5
Year
Topic
Type